Novo Nordisk stumbles against Eli Lilly in GLP-1 drug battle. Which stock is best?
In the battle between weight-loss drug companies, Eli Lilly has emerged as the clear winner for investors. The…
We created health guidelines for fighting loneliness
Social isolation kills. It increases your risk of death by 30% — roughly the same as smoking cigarettes…
Johnson & Johnson expanding neurovascular R&D activities in Galway
The expansion will enable Johnson & Johnson to target specific medical concerns, grow its teams and develop new…
Evoke phase 3 trials did not demonstrate
Bagsværd, Denmark, 24 November 2025 – Novo Nordisk today announced the top-line results from the 2-year primary analysis of…
Doctor Says This Women-Specific Health Problem Is The Greatest Single Failure Of The Modern Medical System
For women, the healthcare system is constantly working against them. From being ignored or even dismissed by professionals…
‘X-ray car’ sent to check elderly patients in Staffordshire after falls
Kerry AshdownLocal Democracy Reporter LDRS A mobile X-ray unit will be on the road from 1 December to…
Standard X-rays to stay free despite fee overhaul at Hong Kong public hospitals
Standard X-ray services at Hong Kong’s public hospitals will remain free under a medical fee reform that will…
The 18 Most Promising Startups in Healthcare of 2025, According to VCs
Nominated by: Blake Wu, NEA (an investor) Total funding: $101 million, according to the company. What it does:…
Novo Nordisk shares plunge after Alzheimer’s drug trial fails to hit key target
The Novo Nordisk A/S headquarters in Bagsvaerd, Denmark, on Wednesday, Nov. 5, 2025. Nichlas Pollier | Bloomberg |…
Calls to resolve ‘unacceptable’ delay as 46,000 patients wait more than 18 months for scans
More than 46,000 people have waited longer than 18 months for vital scans, which could include diagnoses of…
Trump expected to unveil new health care cost proposal
President Donald Trump is planning to unveil a new proposal for addressing health care costs as soon as…
Johnson & Johnson Buys Prostate Cancer Treatment-Maker Halda for $3.1 Billion
Johnson & Johnson has had the year 2025 circled, highlighted, bolded and underlined on its calendar for a…